Design of a Potent Combined Pseudopeptide Endothelin-A/Endothelin-B Receptor Antagonist, Ac-dBhg16-Leu-Asp-Ile-[NMe]Ile-Trp21(PD 156252): Examination of Its Pharmacokinetic and Spectral Properties
Endothelin Receptor Antagonists
Magnetic Resonance Spectroscopy
Endothelin-1
Protein Conformation
Molecular Sequence Data
In Vitro Techniques
Pulmonary Artery
Receptor, Endothelin A
Receptor, Endothelin B
01 natural sciences
Muscle, Smooth, Vascular
Rats
0104 chemical sciences
3. Good health
Femoral Artery
Kinetics
Drug Design
Animals
Humans
Amino Acid Sequence
Rabbits
Oligopeptides
Muscle Contraction
DOI:
10.1021/jm970161m
Publication Date:
2002-07-26T05:10:41Z
AUTHORS (8)
ABSTRACT
The endothelins (ETs) are a family of bicyclic 21-amino acid peptides that are potent and prolonged vasoconstrictors. It has been shown that highly potent combined ETA/ETB receptor antagonists can be developed from the C-terminal hexapeptide of ET (His16-Leu17-Asp18-Ile19-Ile20-Trp21), such as Ac-(D)Dip16-Leu-Asp-Ile-Ile-Trp21 (PD 142893) and Ac-DBhg16-Leu-Asp-Ile-Ile-Trp21 (PD 145065). However, these compounds are relatively unstable to enzymatic proteolysis as determined in an in vitro rat intestinal perfusate assay. This instability is thought to be due to carboxypeptidase activity. In fact, incubation of PD 145065 with carboxypeptidase inhibitors greatly increased its half-life in rat intestinal perfusate. By performing a reduced amide bond and N-methyl amino acid scan, it was discovered that N-methylation of Ile-20 resulted in a compound (Ac-DBhg16-Leu-Asp-Ile-[NMe]Ile-Trp21, PD 156252) that retained full receptor affinity at both endothelin receptor subtypes along with enhanced proteolytic stability and cellular permeability. Interestingly, N-methylation of this bond allows the cis configuration to be readily accessible which greatly alters the preferred structure of the entire molecule and may be responsible for the observed enhanced metabolic stability.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (72)
CITATIONS (85)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....